Clinical Trials

198 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07624864 2026-06-03

A Study to Evaluate the Safety, Tolerability, PK and Efficacy of Hemay5087 in Patients With Advanced Solid Tumors

24 enrolled

Solid Tumors

NCT07620041 2026-06-02

QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction

48 enrolled

Refractory or Relapsed Solid Tumors

NCT07617337 2026-06-01

AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer

102 enrolled

Thoracic

ALK Positive Non-small Cell Lung Cancer

NCT07617727 2026-06-01

A Phase I Study of JSKN021 in Advanced Solid Tumors

199 enrolled

Advanced Malignant Solid Tumors

NCT07618377 2026-06-01

Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments

10 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07619287 2026-06-01

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies

118 enrolled

Myeloid Malignancy

NCT07543055 2026-05-29

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

36 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT07614646 2026-05-29

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients

13 enrolled

Thoracic

Squamous Non-Small Cell Lung Cancer sqNSCLC

NCT07615413 2026-05-29

Phase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors.

636 enrolled

KRAS G12C Mutation Advanced Solid Tumor

NCT07615894 2026-05-29

WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)

9 enrolled

Thoracic

Pleural Effusion, Malignant

NCT07616089 2026-05-29

FXS0683-001

LymphoidMyeloidOther hematologic neoplasm

228 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07611149 2026-05-28

Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma

12 enrolled

Plasma cell

Multiple Myeloma

NCT07612488 2026-05-28

A Study of CS231295 in Patients With Advanced Solid Tumors

42 enrolled

Tumor-Agnostic

Neoplasms

NCT07609706 2026-05-27

A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment

20 enrolled

Plasma cell

Multiple Myeloma

NCT07610148 2026-05-27

A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of HRS-6209 in Healthy Participants

21 enrolled

Breast

Breast Neoplasms

NCT07176975 2026-05-26

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

46 enrolled

Solid Tumors

NCT07606612 2026-05-26

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

31 enrolled

Solid Tumor

NCT07607054 2026-05-26

A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

50 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT07600749 2026-05-22

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

120 enrolled

Tumor-Agnostic

Neoplasms

NCT07601243 2026-05-22

Study of GS-2426 in Participants With Advanced Solid Tumors

174 enrolled

Advanced Solid Tumors

NCT07601334 2026-05-22

Safety and Activity of HF50 in Patients With Advanced Solid Tumors

45 enrolled

Advanced Solid Tumors

NCT07601620 2026-05-22

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer

258 enrolled

Breast

Breast Neoplasms

NCT07603479 2026-05-22

A Phase I Study of JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

14 enrolled

Lymphoma, Non-Hodgkin, Neoplasms

NCT07600554 2026-05-20

SWAP

20 enrolled

Genitourinary

Prostatic Neoplasms

NCT07596381 2026-05-19

FAK Inhibitor in Patients With Advanced Solid Tumors

75 enrolled

Advanced Solid Tumors

NCT07593092 2026-05-18

Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

90 enrolled

Gynecologic

Ovarian Neoplasms

NCT07591285 2026-05-15

A Study of SYS6051 in Subjects With Advanced Solid Tumors

114 enrolled

Advanced Solid Tumors

NCT07581509 2026-05-14

Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma

138 enrolled

Dermatologic

Melanoma

NCT06549751 2026-05-13

PANACEA

38 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07101328 2026-05-13

BAF_FRontier-1

215 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07573111 2026-05-13

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

LymphoidMyeloidOther hematologic neoplasm

12 enrolled

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07583212 2026-05-13

Phase I Study of HRS-1635 in B-cell Malignancies

180 enrolled

B-cell Malignancy

NCT07583316 2026-05-13

A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

GastrointestinalHead & NeckThoracic

192 enrolled

Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis

NCT07583771 2026-05-13

A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma

186 enrolled

LymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT07580833 2026-05-12

A Study to Investigate the Effect of Food on the Bioavailability of Oral Paclitaxel Administered With Encequidar in Participants With Advanced Solid Tumors

46 enrolled

Breast

Breast Neoplasms

NCT07558915 2026-05-11

A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

160 enrolled

Plasma cell

Multiple Myeloma

NCT06970496 2026-05-05

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

48 enrolled

Recurrence, Lymphoma, B-Cell

NCT07566247 2026-05-05

A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor

96 enrolled

Advanced Malignant Solid Tumors

NCT07566897 2026-05-05

A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors

96 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07567859 2026-05-05

A Study of HS-10587 in Patients With Advanced Solid Tumors

362 enrolled

MTAP Deletion

NCT07563829 2026-05-04

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

81 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07558200 2026-04-30

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors